FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice.
PEPTIDE RESEARCH TOPIC
FOXO4-DRI Research Peptide
FOXO4-DRI is an experimental peptide investigated in senescent-cell biology. Explore the FOXO4-p53 interaction, preclinical findings, and translational limitations.
TOPIC OVERVIEW
About FOXO4-DRI
Identity and names
FOXO4-DRI identifies a D-retro-inverso peptide design associated with FOXO4 research. It is not synonymous with the endogenous FOXO4 protein.
Compound type
It is an experimental synthetic peptide. Sequence, stereochemistry, and characterization are relevant to reproducing an experiment.
Mechanism
Mechanistic work investigates disruption of FOXO4-p53 interactions and the survival of senescent cells. Selectivity is dependent on model and conditions.
Research focus and evidence
Foundational evidence comes from cellular and mouse studies. Senescent-cell clearance in those models does not establish general human rejuvenation.
Regulatory status and limits
The primary studies cited here do not establish an approved human anti-aging treatment or a human dosing protocol. Clinical efficacy and long-term safety require separate evidence.
Topics covered
- FOXO4 and p53
- senescence and apoptosis
- D-retro-inverso design
- mouse evidence
- translation to humans
Common names and related terms: FOXO4-DRI, FOXO4 DRI
RESEARCH SUMMARY
What Is FOXO4-DRI?
LAST VERIFIEDOctober 7, 2026
The foundational Cell study examined FOXO4-p53 interactions and a designed peptide in senescent cells and mouse models. Reported tissue-function changes provide a preclinical rationale for investigation, not proof of human rejuvenation. Foundational FOXO4-DRI study
A later study examined senescent Leydig cells and testosterone-related outcomes in aged mice. Its organ-specific animal findings should remain distinct from clinical claims about fertility, hormones, or lifespan in people. Aged-mouse Leydig-cell study
EVIDENCE PROFILE
FOXO4-DRI Research Evidence
A concise view of registered clinical research, PubMed-indexed literature, evidence stage, and important limitations.
LAST VERIFIEDOctober 7, 2026
Registered records0
Active studies0
Completed studies0
PubMed records19
Compound typeIt is an experimental synthetic peptide. Sequence, stereochemistry, and characterization are relevant to reproducing an experiment.
AliasesFOXO4-DRI, FOXO4 DRI
Evidence stageFoundational evidence comes from cellular and mouse studies. Senescent-cell clearance in those models does not establish general human rejuvenation.
U.S. regulatory contextThe primary studies cited here do not establish an approved human anti-aging treatment or a human dosing protocol. Clinical efficacy and long-term safety require separate evidence.
Selected registered research
No matching intervention record was found in ClinicalTrials.gov during this verification. This does not mean that no research exists.
Selected PubMed records
Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.
How to interpret this profile
Registry and publication counts describe discoverable records, not proof of effectiveness or safety. Study design, compound identity, population, endpoints, and regulatory context must be reviewed individually.
START HERE
Essential FOXO4-DRI guides
What Is FOXO4-DRI? Senolytic Peptide ExplainedCurious what is FOXO4-DRI? Learn how this experimental senolytic peptide targets senescent cells, what mice studies show, and why it's not FDA-approved.FOXO4-DRI Protocol: Dosing, Research, and SafetyThe FOXO4-DRI protocol is a research-only senolytic approach studied in mice. Learn about dosing, mechanisms, safety, and what human trials show.FOXO4-DRI 10mg: Senolytic Peptide Research GuideFOXO4-DRI 10mg is a research-grade senolytic peptide studied for clearing senescent cells. Learn how it works, how it compares, and its legal status.
FOXO4-DRI KNOWLEDGE ARTICLESPage 1 of 2
KNOWLEDGE ARTICLE
↗FOXO4-DRI Side Effects: What Research Actually Shows
FOXO4-DRI side effects are unconfirmed in humans because no clinical trials exist. Here's what animal studies and the peptide's biology suggest about risks.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Benefits: What Research Shows So Far
FOXO4-DRI benefits in research center on senescent cell clearance and tissue function. Learn what studies show, dosage questions, and safety limits.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Reviews: What Users and Research Say
FOXO4-DRI reviews are mostly anecdotal reports from research peptide users. Here's what the evidence shows, plus safety and sourcing warnings.
KNOWLEDGE ARTICLE
↗FOXO4-DRI 10mg: Senolytic Peptide Research Guide
FOXO4-DRI 10mg is a research-grade senolytic peptide studied for clearing senescent cells. Learn how it works, how it compares, and its legal status.
KNOWLEDGE ARTICLE
↗FoxO4-DRI Dosage Bodybuilding: Research Overview
FoxO4-DRI dosage in bodybuilding is largely anecdotal. Here's what research actually shows about this senolytic peptide, plus safety and legal caveats.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Cancer Research: What Studies Show
FOXO4-DRI cancer research explores how this senolytic peptide targets senescent cells. Learn what studies show, dosing questions, and safety limits.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Hair Loss: What Research Actually Shows
FOXO4-DRI hair loss claims trace to a mouse study, not human trials. Here's what the research shows, what's unproven, and the real safety risks.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Reddit: What Users Say About the Peptide
FOXO4-DRI Reddit threads debate this senolytic peptide's dosing, risks, and results. Here's what research actually shows and what to know before buying.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Dosage Calculator: What It Can and Can't Do
A foxo4-dri dosage calculator can convert numbers, but no human dose is established. Learn what these tools can and can't tell you before you rely on one.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Sequence: What It Is and How It Works
The FOXO4-DRI sequence is a D-retro-inverso peptide derived from FOXO4. Learn what the sequence means, how it's used in research, and key safety facts.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Protocol: Dosing, Research, and Safety
The FOXO4-DRI protocol is a research-only senolytic approach studied in mice. Learn about dosing, mechanisms, safety, and what human trials show.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Dosage: What Research Actually Shows
There is no established FOXO4-DRI dosage for humans. Learn what mouse studies used, why human data is missing, and important safety concerns.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Dosage Chart: Research vs. Community
FOXO4-DRI dosage chart explained: no official human dosing exists. See preclinical amounts, community protocols, safety warnings, and consult a doctor.
KNOWLEDGE ARTICLE
↗What Is FOXO4-DRI? Senolytic Peptide Explained
Curious what is FOXO4-DRI? Learn how this experimental senolytic peptide targets senescent cells, what mice studies show, and why it's not FDA-approved.
KNOWLEDGE ARTICLE
↗FOXO4-D Retro-Inverso DRI Peptide: What to Know
FOXO4-D retro-inverso DRI peptide is a research-only senolytic studied for clearing senescent cells. Learn its mechanism, dosing, and safety limits.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Experience: What Users Report and What's Known
FOXO4-DRI experience reports from users describe energy and skin changes, but human data is limited. Here's what research shows, plus safety notes.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Results: What Research Actually Shows
FOXO4-DRI results come from mouse studies, not human trials. Here's what the research shows, how the peptide works, and key safety limits to know.
KNOWLEDGE ARTICLE
↗Buy FOXO4-DRI Peptide: Price, Dosage & Safety
Want to buy FOXO4-DRI peptide? Compare typical prices, vial sizes, and COA checks, plus why this senolytic research peptide is not FDA-approved for human use.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Before and After: What Research Shows
FOXO4-DRI before and after results come from mouse studies, not human trials. Learn what the research shows, what is unproven, and safety facts.
KNOWLEDGE ARTICLE
↗FOXO4-DRI Treatment: What Research Shows
FOXO4-DRI treatment is an experimental senolytic peptide with no FDA approval or human dosing data. Learn what research shows, plus safety and legal risks.